Allogene Therapeutics
ALLO
ALLO
191 hedge funds and large institutions have $1.15B invested in Allogene Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
+31
Holders Change %
+19.38%
% of All Funds
3.3%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
44
Increased
64
Reduced
49
Closed
12
Calls
$1.99M
Puts
$1.67M
Net Calls
+$318K
Net Calls Change
-$674K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$72.1M |
| 2 |
Capital International Investors
Los Angeles,
California
|
$57.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$9.64M |
| 4 |
Two Sigma Investments
New York
|
$9M |
| 5 |
Millennium Management
New York
|
$15.1M |
Top Sellers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
$48.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$77.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
$934K |
| 4 |
JPMorgan Chase & Co
New York
|
$42.8M |
| 5 |
Morgan Stanley
New York
|
$6.65M |
